Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: A preliminary study

Biomedicine and Pharmacotherapy

Volumn 61, Issue 2-3, 2007, Pages 148-153

  Monzote, Lianet ^a   Montalvo, Ana M ^a   Scull, Ramón ^b   Miranda, Migdalia ^b   Abreu, Juan ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b Institute of Pharmacy and Food   (Cuba)

Author keywords

Balb c; Chenopodium ambrosioides; Essential oil; Leishmania amazonensis; Treatment

Indexed keywords

ESSENTIAL OIL; MIGLYOL;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHENOPODIUM AMHROSIOIDES; CONTROLLED STUDY; DEATH; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GOOSEFOOT; LEISHMANIA; LEISHMANIASIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PARASITE; PERITONEAL CAVITY; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS; TOXICITY TESTING; TRADITIONAL MEDICINE; TREATMENT OUTCOME; TROPICAL DISEASE;

ADMINISTRATION, ORAL; ANIMALS; ANTIPROTOZOAL AGENTS; CHENOPODIUM AMBROSIOIDES; DRUG RESISTANCE; FEMALE; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAPERITONEAL; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; OILS, VOLATILE; PARASITIC SENSITIVITY TESTS; PLANT OILS;

EID: 34147152205     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.12.001     Document Type: Article

References (24)

1. Mauël J. Vaccination against Leishmania infections. Current Opinion in Drug Targets -Immunology Endocrinology and Metabolic Disorders 2 (2002) 201-226
2. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Transaction Royal Society of Tropical Medicine and Hygiene 95 (2001) 239-243
3. Croft S.L., and Yardley V. Chemotherapy of Leishmaniasis. Current Opinions in Pharmaceutical Desing 8 (2002) 319-342
4. Berman J.D. Human Leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clinical Infection Diseases 24 (1997) 684-703
5. Chan M.J., and Peña L.M. Plant natural products with leishmanicidal activity. Natural Product Report 18 (2001) 674-688
6. Kiuchi F., Itano Y., Uchiyama N., Honda G., Tsubouchi A., Nakajima-Shimada J., et al. Monoterpene hidroperoxides with trypanocidal activity from Chenopodium ambrosioides. Journal Natural Products 65 (2002) 509-512
7. Pollack Y., Segal R., and Golenser J. The effect of ascaridole on the in vitro development of Plasmodium falciparum. Parasitology Research 76 (1990) 570-572
8. Giove N.R.A. Tradicional medicine in the treatment of enteroparasitosis. Revista de Gastroenterologia de Peru 16 (1996) 197-202
9. Monzote L., Montalvo A.M., Almanonni A.S., Scull R., Miranda M., and Abreu J. Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis. Chemotherapy 52 (2006) 130-136
10. Buffet P.A., Sulahian A., Garin Y.J.F., Nassar N., and Derouin F. Culture Microtitration a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrobial Agents and Chemotherapy 39 (1995) 2167-2168
11. Bodley A.L., McGarry M.W., and Shapiro T.A. Drug cytotoxicity assay for African Trypanosomes and Leishmania Species. Journal Infection Diseases 172 (1995) 1157-1159
12. Cauchetier E., Loiseau P.M., Lehman J., Rivollet D., Fleury J., Astier A., et al. Characterisation of atovaquone resistance in Leishmania infantum promastigotes. International Journal of Parasitology 32 (2002) 1043-1051
13. Fournet A., Ferreira M.E., Rojas de Arias A., Torres de Ortiz S., Fuentes S., and Nakayama H. In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of New World cutaneous leishmaniasis caused by Leishmania amazonensis. Antimicrobial Agents and Chemotherapy 40 (1996) 2447-2451
14. Da Silva S.A.G., Costa S.S., Mendoça S.C.F., Silva E.M., Moraes V.L.G., and Rossi-Bergmann B. Therapeutic effect of oral Kalanchoe pinnata leaf extract in murine leishmaniasis. Acta Tropica 60 (1995) 201-210
15. Chen M., Brogger S., Theander T.G., and Kharazmi A. Antileishmanial activity of Licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. Antimicrobial Agents and Chemotherapy 38 (1994) 1339-1344
16. Dardari Z., Lemrani M., Bahloul A., Sebban A., Hassar M., and Kitane S. Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5′-(3′-phenylisoxazolino)methyl]-8-hydroxyquinoline: preliminary study. Farmaco 59 (2004) 195-199
17. Mullen A.B., Carter K.C., and Baillie A.J. Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis. Antimicrobial Agents and Chemotherapy 41 (1997) 2089-2092
18. Al-Abdely H.M., Graybill J.R., Loebenberg D., and Melby P.C. Efficacy of the triazole SCH56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases. Antimicrobial Agents and Chemotherapy 43 (1999) 2910-2914
19. Garcez L.M., Goto H., Ramos P.K., Briguido M.C., Gomes P.A.F., and Souza R.A. Leishmania (Leishmania) amazonensis-induced cutaneous leishmaniasis in the primate Cebus apella: a model for vaccine trials. International Journal of Parasitology 32 (2002) 1755-1764
20. Garin Y.J.F., Meneceur P., Sulahian A., and Derouin F. Microplate method for obtaining Leishmania clonal populations. Journal of Parasitology 88 (2002) 803-804
21. Genestra M., Echevarria A., Cysne-Finkelstein L., Vignólio-Alves l., and Leon L.L. Effect of amidine derivatives on nitric oxide production by Leishmania amazonensis promastigotes and axenic amastigotes. Nitric Oxide 8 (2003) 1-6
22. Singh T.R., and Sundar S. Identification of a gene linked to drug resistance in field isolates of Leshmania donovani. Annals of Tropical Medicine and Parasitology 96 (2002) 839-841
23. Carrió J., and Portús M. In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate. Pharmacology 2 (2002) 11-15
24. Seifert K., Matu S., Pérez-Victoria F.J., Castanys S., Gamarro F., and Croft S.L. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). International Journal of Antimicrobial Agents 22 (2003) 380-387